Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2022Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36Fernando, S.; Salagaras, T.; Schwarz, N.; Sandeman, L.; Tan, J.T.M.; Xie, J.; Zareh, J.; Jensen, K.; Williamson, A.; Dimasi, C.; Chhay, P.; Toledo-Flores, D.; Long, A.; Manavis, J.; Worthington, M.; Fitridge, R.; Di Bartolo, B.A.; Bursill, C.A.; Nicholls, S.J.; Proud, C.G.; et al.
2022Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial InfarctionNicholls, S.J.; Kataoka, Y.; Nissen, S.E.; Prati, F.; Windecker, S.; Puri, R.; Hucko, T.; Aradi, D.; Herrman, J.-P.R.; Hermanides, R.S.; Wang, B.; Wang, H.; Butters, J.; Di Giovanni, G.; Jones, S.; Pompili, G.; Psaltis, P.J.
2022Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3 (α-Gal) is associated with noncalcified plaque, obstructive coronary artery disease, and ST-segment-elevated myocardial infarctionVernon, S.T.; Kott, K.A.; Hansen, T.; Finemore, M.; Baumgart, K.W.; Bhindi, R.; Yang, J.; Hansen, P.S.; Nicholls, S.J.; Celermajer, D.S.; Ward, M.R.; van Nunen, S.A.; Grieve, S.M.; Figtree, G.A.
2022Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.Figtree, G.A.; Vernon, S.T.; Hadziosmanovic, N.; Sundström, J.; Alfredsson, J.; Nicholls, S.J.; Chow, C.K.; Psaltis, P.; Røsjø, H.; Leósdóttir, M.; Hagström, E.
2022Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocolMarschner, S.; Wing-Lun, E.; Chow, C.; Maple-Brown, L.; Graham, S.; Nicholls, S.J.; Brown, A.; Wood, A.; Ihdayhid, A.; Von Huben, A.; Zaman, S.